Bayer Yakuhin

FunderResearch funding and supported work

Bayer Yakuhin is a funder indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,245 works.

1,245

Works

IDs:OpenAlex

What are the most-cited papers on Bayer Yakuhin?

ScholarIQmost cited works

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Helen M. Colhoun, Ildiko Lingvay, Paul Brown, John Deanfield, Kirstine Brown‐Frandsen, Steven E. Kahn, Jorge Plutzky, Koichi Node, Alexander Parkhomenko, Lars Rydén, John Wilding, Johannes F.E. Mann, Katherine R. Tuttle, Thomas Idorn, Naveen Rathor, A. Michael Lincoff

Nature Medicine. 2024209 CitationsOPEN ACCESS

A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease

Naoki Sato, Masayoshi Ajioka, Takahisa Yamada, Masaharu Kato, Masafumi Myoishi, Takashi Yamada, So-Young Kim, Christina Nowack, Peter Kolkhof, Tsuyoshi Shiga, on behalf of the ARTS-HF Japan study group

Circulation Journal. 201677 CitationsOPEN ACCESS

Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Eplerenone in Japanese Patients With Chronic Heart Failure (J-EMPHASIS-HF)

Hiroyuki Tsutsui, Hiroshi Ito, Masafumi Kitakaze, Issei Komuro, Toyoaki Murohara, Tohru Izumi, Kenji Sunagawa, Yoshio Yasumura, Masafumi Yano, K. Yamamoto, Tsutomu Yoshikawa, Takayoshi Tsutamoto, Junwei Zhang, Akifumi Okayama, Yoshihiko Ichikawa, Kazuhiro Kanmuri, Masunori Matsuzaki, for the J-EMPHASIS-HF Study Group

Circulation Journal. 201738 CitationsOPEN ACCESS

Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)

Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, Yosuke Okada, Satomi Sonoda, Keiichi Torimoto, Satoru Suwa, Hiroki Teragawa, Motoaki Miyazono, Makoto Fukuda, Keisuke Yonezu, Naohiko Takahashi, Yuichi Yoshida, Kenichi Tanaka, Michio Shimabukuro, Yuki Hotta, Masao Moroi, Hiroki Niikura, Keisuke Kida, Kenichi Yokota, Daiju Fukuda, Kengo Tanabe, Yu Horiuchi, Shigeru Toyoda, Isao Taguchi, Hisako Yoshida, Toru Miyoshi, Masaomi Nangaku, Hirotaka Shibata, Koichi Node, on behalf of the FIVE-STAR Investigators

Cardiovascular Diabetology. 20257 CitationsOPEN ACCESS